Natural Right Medicines India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 13-12-2024
- Paid Up Capital ₹ 0.10 M
as on 13-12-2024
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2020
- Revenue %
(FY 2020)
- Profit 64.45%
(FY 2020)
- Ebitda 64.45%
(FY 2020)
- Net Worth -196.21%
(FY 2020)
- Total Assets -20.07%
(FY 2020)
About Natural Right Medicines India
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Radhakrishna Vegesana and Harikrishnakankipati serve as directors at the Company.
- CIN/LLPIN
U24100TG2016PTC103183
- Company No.
103183
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Feb 2016
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Natural Right Medicines India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Radhakrishna Vegesana  | Director | 08-Feb-2016 | Current |
| Harikrishnakankipati | Director | 02-Dec-2019 | Current |
Financial Performance and Corporate Structure Insights of Natural Right Medicines India.
Natural Right Medicines India Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 64.45% increase in profit. The company's net worth observed a substantial decline by a decrease of 196.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Natural Right Medicines India?
In 2018, Natural Right Medicines India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Paschal Form Work (India) Private LimitedActive 16 years 7 monthsRadhakrishna Vegesana is a mutual person
- Royals Marine Food Private LimitedActive 19 years 8 days
Radhakrishna Vegesana and Harikrishnakankipati are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Natural Right Medicines India?
Unlock and access historical data on people associated with Natural Right Medicines India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Natural Right Medicines India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Natural Right Medicines India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
